Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series
Abstract Aims Diuretic resistance is common in acute decompensated heart failure (ADHF). When loop diuretic monotherapy is ineffective, thiazides are often recommended as adjunctive therapy, but these agents have many side effects and are associated with worsened survival. In contrast, sodium glucos...
Main Authors: | Matthew Griffin, Ralph Riello, Veena S. Rao, Juan Ivey-Miranda, James Fleming, Christopher Maulion, Wendy McCallum, Mark Sarnak, Sean Collins, Silvio E. Inzucchi, Jeffrey M. Testani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12759 |
Similar Items
-
Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients
by: Cesar Ernesto Lam-Chung
Published: (2023-07-01) -
DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS
by: Marina V. Shestakova
Published: (2019-12-01) -
Sodium-glucose cotransporter-2 inhibition and the insulin: Glucagon ratio: Unexplored dimensions
by: Sanjay Kalra, et al.
Published: (2015-01-01) -
Risk of Diabetic Ketoacidosis Associated with Sodium Glucose Cotransporter-2 Inhibitors: A Network Meta-Analysis and Meta-Regression
by: Kannan Sridharan, et al.
Published: (2024-03-01) -
Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
by: Santos Cavaiola T, et al.
Published: (2018-04-01)